论文部分内容阅读
目的:探究兰索拉唑联合凝血酶在上消化道出血治疗中的临床效果。方法:选取在我院被确诊为患有上消化道出血,且在我院接受治疗的82例患者作为探究对象,严格按照随机原则将其分为对照组与观察组,每组患者均有41例,采用兰索拉唑对对照组患者进行治疗,而观察组患者则采用兰索拉唑联合凝血酶进行治疗,观察并对比两组患者的止血效果及临床治疗效果。结果:观察组患者的血压稳定时间、腹痛时间、止血时间均短于对照组,差异具有统计学意义(P<0.05);观察组患者的胃管引流量少于对照组,差异具有统计学意义(P<0.05)。经过治疗后,观察组与对照组患者的总有效率分别为92.68%与75.61%,组间差异率较大(P<0.05),具有统计学意义。结论:治疗上消化道出血,采用兰索拉唑联合凝血酶可有效止血,且能提高临床治疗效果,应予以推广。
Objective: To investigate the clinical effect of lansoprazole combined with thrombin in the treatment of upper gastrointestinal bleeding. Methods: Totally 82 patients diagnosed as having upper gastrointestinal bleeding in our hospital and treated in our hospital were selected as research subjects, and randomly divided into control group and observation group, with 41 cases in each group . The patients in the control group were treated with lansoprazole and the patients in the observation group were treated with lansoprazole and thrombin. The hemostatic effect and clinical effect of the two groups were observed and compared. Results: The blood pressure stabilization time, abdominal pain time and bleeding time in the observation group were shorter than those in the control group (P <0.05). The observation group had less gastric tube drainage than the control group, the difference was statistically significant (P <0.05). After treatment, the total effective rate of observation group and control group patients were 92.68% and 75.61% respectively, and the difference between groups was significant (P <0.05), with statistical significance. Conclusion: The treatment of upper gastrointestinal bleeding, the use of lansoprazole combined with thrombin can effectively stop bleeding, and can improve the clinical effect, should be promoted.